Needs monitoring with quetiapine.
10.1097/CM9.0000000000000025
- Author:
Pugazhenthan THANGARAJU
1
;
Sajitha VENKATESAN
2
;
Vineet Kumar CHADHA
2
Author Information
1. Department of Pharmacology, All India Institute of Medical Sciences, Raipur, Chhattisgarh 492099, India.
2. Clinical Division, Central Leprosy Teaching and Research Institute, Chengalpattu, Tamilnadu 603001, India.
- Publication Type:Journal Article
- MeSH:
Acute Disease;
Antipsychotic Agents;
adverse effects;
Drug Synergism;
Humans;
Pancreatitis;
chemically induced;
Quetiapine Fumarate;
adverse effects
- From:
Chinese Medical Journal
2019;132(1):113-114
- CountryChina
- Language:English
